Vytrus Biotech S.A. Financial Flexibility Index
Vytrus Biotech S.A. financial flexibility index. Vytrus Biotech S.A. (VYT) has a Financial Flexibility Index of 0.22x as of December 2022. Free cash flow of €719.71K (operating CF €225.55K minus capex €494.16K) represents 0% of total liabilities (€3.25 Million). See VYT cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Vytrus Biotech S.A. (2020–2025)
Financial flexibility index of Vytrus Biotech S.A. from 2020 to 2025. Historical Financial Flexibility Index trend for Vytrus Biotech S.A. across 6 annual periods. Check VYT cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Vytrus Biotech S.A. Financial Flexibility Index by Year (2020–2025)
Vytrus Biotech S.A. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Vytrus Biotech S.A.. For the full cash flow conversion analysis, see cash efficiency ratio of Vytrus Biotech S.A..
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | €6.58 Million | €3.90 Million | €4.35 Million | ▲ +90.3% |
| 2024 | 0.79x | €3.05 Million | €1.84 Million | €3.84 Million | ▲ +54.2% |
| 2023 | 0.51x | €2.07 Million | €904.39K | €4.02 Million | ▲ +132.5% |
| 2022 | 0.22x | €719.71K | €225.55K | €3.25 Million | ▼ -9.8% |
| 2021 | 0.25x | €719.74K | €447.92K | €2.93 Million | ▲ +520.1% |
| 2020 | 0.04x | €102.86K | €-132.47K | €2.60 Million | — |